Printer Friendly

Pacemaker designed for young hearts.

PACEMAKER DESIGNED FOR YOUNG HEARTS

The American Heart Association reports that about 1.5 million American children have various types of heart disease and that approximately 25,000 babies are born annually with heart defects. Many such children need pacemakers to keep their hearts beating steadily, but pacemakers that keep the heart beating at a single, steady rate can cause breathlessness, dizziness or fainting as the result of exercise, excitement or stress. Fortunately, a type of pacemaker already widely used by adults has been developed for use in young hearts as well. The pacemaker changes its rate in response to changes in the patient's metabolism. The pacemaker, known as the "Meta-MV," is manufactured by Telelectronic Pacing Systems of Denver, Colo., and the surgery costs "somewhere in the thousands," according to a company spokesperson.
COPYRIGHT 1990 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1990 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Telectronic Pacing Systems' Meta-MV
Publication:Medical Update
Date:Oct 1, 1990
Words:133
Previous Article:A very sticky problem.
Next Article:Unraveling the vitamin A mystery.
Topics:


Related Articles
NEW MEDTRONIC PACEMAKER LEAD FOR INFANTS AND CHILDREN CLEARED FOR MARKETING BY FDA.
BIOTRONIK Announces FDA Approval of ACTROS SLR+ Pacemaker VDDR System.
Vitatron Adds to Its List of Innovations in Heart Pacing Systems Now Available in The U.S.
St. Jude Medical Announces U.S. FDA Approval for Company's Newest Pacemakers; Victory Pacemaker Family Launched Immediately in U.S. and Europe.
Medtronic Announces Market Introduction and FDA Approval of Three New Pacemakers; Physiologic, Fully Automatic Adapta Pacemaker Portfolio Safeguards...
Similar pattern of diastolic function adaptation of both ventricles to programmed atrioventricular interval modification in patients with DDD...
Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?/Hipertrofik kardiyomiyopatide pacing: Terapotik opsiyon mu?
The Sorin Group Announces CE Mark and First Implants of Advanced, Next-Generation Pacemakers in Europe.
Transvenous cardiac pacing in children: problems and complications during follow-up / Cocuklarda transvenoz pacemaker tedavisi deneyimlerimiz:...
Pacemaker lead failure due to crush injury / Ezilme hasarina bagli kalici kalp pili elektrod kusuru.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters